Free Vision Screenings at SUNY Downstate January 26:
Jan 21, 2009
Free Vision Screenings at SUNY Downstate January 26:
Diagnosed Early, Glaucoma Can Be Easily Controlled
Brooklyn, NY - SUNY Downstate Health Sciences University’s Department of Ophthalmology in association with the Friends of the Congressional Glaucoma Caucus Foundation will hold free glaucoma screenings at SUNY Downstate’s University Hospital at Downstate on January 26 from 9:00 a.m. to 3:00 p.m. The address is 445 Lenox Road in the East Flatbush section of Brooklyn. No appointment is required for the free screenings, which will be held in the University Hospital lobby.
Glaucoma is the major cause of preventable blindness in the U.S. More than three million Americans have glaucoma. Glaucoma shows no symptoms in its early stages, but the good news is that with early diagnosis and medication, glaucoma can be easily controlled.
###
About SUNY Downstate Health Sciences University
Downstate Health Sciences University in Brooklyn is one of four academic health centers (AMCs) in The State University of New York (SUNY) 64-campus system and the only SUNY AMC in New York City dedicated to health education, research, and patient care for the borough’s 2.7 million residents. Its flagship hospital, University Hospital at Downstate (UHD), is a teaching hospital and benefits from the expertise of Downstate’s exceptional medical school and world-class academic center research facilities. With a staff of over 800 physicians representing 53 specialties and subspecialties, Downstate offers comprehensive healthcare services to the community.
UHD provides high-risk neonatal and infant services, pediatric nephrology, and dialysis for kidney diseases and is the only kidney transplantation program in Brooklyn. Beyond its clinical expertise, Downstate houses a range of esteemed educational institutions, including its College of Medicine, College of Nursing, School of Health Professions, School of Graduate Studies, and School of Public Health. Downstate fosters innovation through its multifaceted biotechnology initiative, the Biotechnology Incubator and BioBAT, which support early-stage and more mature biotech companies.